BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26968870)

  • 1. Ethics and social acceptability of a proposed clinical trial using maternal gene therapy to treat severe early-onset fetal growth restriction.
    Sheppard M; Spencer RN; Ashcroft R; David AL;
    Ultrasound Obstet Gynecol; 2016 Apr; 47(4):484-91. PubMed ID: 26968870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EVERREST prospective study: a 6-year prospective study to define the clinical and biological characteristics of pregnancies affected by severe early onset fetal growth restriction.
    Spencer R; Ambler G; Brodszki J; Diemert A; Figueras F; Gratacós E; Hansson SR; Hecher K; Huertas-Ceballos A; Marlow N; Marsál K; Morsing E; Peebles D; Rossi C; Sebire NJ; Timms JF; David AL;
    BMC Pregnancy Childbirth; 2017 Jan; 17(1):43. PubMed ID: 28114884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perinatal and long-term effects of maternal uterine artery adenoviral VEGF-A165 gene therapy in the growth-restricted guinea pig fetus.
    Vaughan OR; Rossi CA; Ginsberg Y; White A; Hristova M; Sebire NJ; Martin J; Zachary IC; Peebles DM; David AL
    Am J Physiol Regul Integr Comp Physiol; 2018 Aug; 315(2):R344-R353. PubMed ID: 29847165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placenta-directed gene therapy for fetal growth restriction.
    Krishnan T; David AL
    Semin Fetal Neonatal Med; 2017 Dec; 22(6):415-422. PubMed ID: 28522033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uteroplacental adenovirus vascular endothelial growth factor gene therapy increases fetal growth velocity in growth-restricted sheep pregnancies.
    Carr DJ; Wallace JM; Aitken RP; Milne JS; Mehta V; Martin JF; Zachary IC; Peebles DM; David AL
    Hum Gene Ther; 2014 Apr; 25(4):375-84. PubMed ID: 24593228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal uterine artery VEGF gene therapy for treatment of intrauterine growth restriction.
    David AL
    Placenta; 2017 Nov; 59 Suppl 1():S44-S50. PubMed ID: 29031540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Human Placental Studies to Support Adenovirus-Mediated VEGF-D
    Desforges M; Rogue A; Pearson N; Rossi C; Olearo E; Forster R; Lees M; Sebire NJ; Greenwood SL; Sibley CP; David AL; Brownbill P
    Hum Gene Ther Clin Dev; 2018 Mar; 29(1):10-23. PubMed ID: 29228803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-trimester screening with specific algorithms for early- and late-onset fetal growth restriction.
    Crovetto F; Triunfo S; Crispi F; Rodriguez-Sureda V; Roma E; Dominguez C; Gratacos E; Figueras F
    Ultrasound Obstet Gynecol; 2016 Sep; 48(3):340-8. PubMed ID: 26846589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sildenafil on maternal hemodynamics in pregnancies complicated by severe early-onset fetal growth restriction: planned subgroup analysis from a multicenter randomized placebo-controlled double-blind trial.
    Khalil A; Sharp A; Cornforth C; Jackson R; Mousa H; Stock S; Harrold J; Turner MA; Kenny LC; Baker PN; Johnstone ED; Von Dadelszen P; Magee L; Papageorghiou AT; Alfirevic Z
    Ultrasound Obstet Gynecol; 2020 Feb; 55(2):198-209. PubMed ID: 31432556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal Therapy with Ad.VEGF-A
    Swanson AM; Rossi CA; Ofir K; Mehta V; Boyd M; Barker H; Ledwozyw A; Vaughan O; Martin J; Zachary I; Sebire N; Peebles DM; David AL
    Hum Gene Ther; 2016 Dec; 27(12):997-1007. PubMed ID: 27530140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians.
    Vayssière C; Sentilhes L; Ego A; Bernard C; Cambourieu D; Flamant C; Gascoin G; Gaudineau A; Grangé G; Houfflin-Debarge V; Langer B; Malan V; Marcorelles P; Nizard J; Perrotin F; Salomon L; Senat MV; Serry A; Tessier V; Truffert P; Tsatsaris V; Arnaud C; Carbonne B
    Eur J Obstet Gynecol Reprod Biol; 2015 Oct; 193():10-8. PubMed ID: 26207980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are maternal hemodynamic indices markers of fetal growth restriction in pregnancies with a small-for-gestational-age fetus?
    Perry H; Lehmann H; Mantovani E; Thilaganathan B; Khalil A
    Ultrasound Obstet Gynecol; 2020 Feb; 55(2):210-216. PubMed ID: 31381215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does Vascular Endothelial Growth Factor Gene Therapy Safely Improve Outcome in Severe Early-Onset Fetal Growth Restriction? (EVERREST).
    Hum Gene Ther Clin Dev; 2015 Jun; 26(2):82-4. PubMed ID: 26086754
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction.
    Groom KM; David AL
    Am J Obstet Gynecol; 2018 Feb; 218(2S):S829-S840. PubMed ID: 29229321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral-placental-uterine ratio as novel predictor of late fetal growth restriction: prospective cohort study.
    MacDonald TM; Hui L; Robinson AJ; Dane KM; Middleton AL; Tong S; Walker SP
    Ultrasound Obstet Gynecol; 2019 Sep; 54(3):367-375. PubMed ID: 30338593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy gets a high-stakes test.
    Couzin-Frankel J
    Science; 2016 Apr; 352(6283):286. PubMed ID: 27081052
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of Doppler ultrasound at time of diagnosis of late-onset fetal growth restriction in predicting adverse perinatal outcome: prospective cohort study.
    Rizzo G; Mappa I; Bitsadze V; Słodki M; Khizroeva J; Makatsariya A; D'Antonio F
    Ultrasound Obstet Gynecol; 2020 Jun; 55(6):793-798. PubMed ID: 31343783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protect-me: a parallel-group, triple blinded, placebo-controlled randomised clinical trial protocol assessing antenatal maternal melatonin supplementation for fetal neuroprotection in early-onset fetal growth restriction.
    Palmer KR; Mockler JC; Davies-Tuck ML; Miller SL; Goergen SK; Fahey MC; Anderson PJ; Groom KM; Wallace EM
    BMJ Open; 2019 Jun; 9(6):e028243. PubMed ID: 31230020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peri- and Postnatal Effects of Prenatal Adenoviral VEGF Gene Therapy in Growth-Restricted Sheep.
    Carr DJ; Wallace JM; Aitken RP; Milne JS; Martin JF; Zachary IC; Peebles DM; David AL
    Biol Reprod; 2016 Jun; 94(6):142. PubMed ID: 27103444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infant outcome after active management of early-onset fetal growth restriction with absent or reversed umbilical artery blood flow.
    Morsing E; Brodszki J; Thuring A; Maršál K
    Ultrasound Obstet Gynecol; 2021 Jun; 57(6):931-941. PubMed ID: 32862450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.